clopenthixol has been researched along with Movement Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryan, EJ; Kumar, A; Purcell, MA | 1 |
Niederhofer, H | 1 |
NOECKER, G | 1 |
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
Kumar, A; Strech, D | 1 |
Achté, KA; Turunen, S | 1 |
Poeldinger, W | 1 |
2 review(s) available for clopenthixol and Movement Disorders
Article | Year |
---|---|
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Humans; Movement Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2017 |
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Humans; Movement Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2005 |
1 trial(s) available for clopenthixol and Movement Disorders
Article | Year |
---|---|
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
4 other study(ies) available for clopenthixol and Movement Disorders
Article | Year |
---|---|
Tizanidine is not effective treating EPMS.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Biperiden; Cholinergic Antagonists; Clonidine; Clopenthixol; Female; Humans; Movement Disorders; Schizophrenia; Treatment Outcome | 2018 |
[CLOPENTHIXOL (CIATYL). NEUROLEPTIC EFFECT WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Drug Therapy; Movement Disorders; Schizophrenia; Toxicology; Tranquilizing Agents | 1964 |
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
Topics: Adult; Aged; Brain Damage, Chronic; Cheek; Chlorpromazine; Chlorprothixene; Clopenthixol; Female; Haloperidol; Humans; Male; Mastication; Middle Aged; Movement Disorders; Parkinson Disease; Perphenazine; Phenothiazines; Reserpine; Thioridazine; Tongue; Tranquilizing Agents | 1967 |
[Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
Topics: Adult; Chlorprothixene; Clopenthixol; Depression; Female; Humans; Male; Middle Aged; Movement Disorders; Oral Manifestations; Paranoid Disorders; Parasympatholytics; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |